AzTrials
AzTrials

WorkplaceWORKCITNCT04928989

Convergence Dialogue Meeting With or Without Neck-specific Exercise Promoting Work Ability

A study testing convergence dialogue meeting in people with Workplace, run by Linkoeping University at 2 sites in Sweden.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

The study will be conducted at workplaces, where the work environment and tasks increase employee risk of developing neck problems. A total of 320 participants will be recruited consecutively and after informed consent randomized to convergenge dialogue meeting with or without neck-specific exercise. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Workplace
What is being tested?
convergence dialogue meeting
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
2 sitesSweden
Study dates
May 2022to Dec 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Self-reported neck problems that the person experiences as troublesome, affecting ability to perform work, and lasting at least 4 weeks.
  • Neck problems as being predominant.
  • Current neck pain ≥ 3 on the numeric rating scale (0-10) [53, 55].
  • Persons of working age, 18-65 years, who have a permanent job.
  • Neck problems clinically verified through a clinical examination to ensure study criteria are met.
  • Answers the baseline questionnaire and attends the first intervention visit.
  • Confirms being motivated to participate and completes and signs informed consent, including approval, to contact their immediate supervisor regarding a CDM.

Who cannot join

  • Red flags and illness/injury that are contraindicated for or hinder exercise or may be confounding factors for the results, such as severe cardiovascular/lung disease, malignancy, severe rheumatic disease, severe neurological disease, spinal cord injury, diagnosed severe mental illness, drug or alcohol abuse, neck surgery, neck fracture or dislocation, severe cervical radiculopathy, myelopathy, general body pain (e.g., fibromyalgia, Ehlers-Danlos syndrome, generalized osteoarthritis).
  • Known pregnancy.
  • Cannot understand/communicate in Swedish and thus would be unable to understand information in the study.
  • For blood samples (not wanting to participate does not constitute exclusion for the randomized controlled trial), the following exclusion criteria are added: increased tendency to bleed and use of blood thinners.
  • For the subgroup for microdialysis (n = 30, consecutively asked, 15 persons/group; not wanting to participate does not constitute exclusion for the randomized controlled trial), the following exclusion criteria are added:
  • Patients who cannot imagine refraining from non-steroid anti-inflammatory drugsduring 2 days before microdialysis may not participate in the microdialysis part of the study.
  • Hypersensitivity to anesthetic and antibiotics.
  • Increased tendency to bleed and use of blood-thinning drugs.

Trial locations and contacts

2 sites in 1 country.

Sweden2 sites
  • Anneli Peolsson

    Linköping, Östergötland County, 58183

  • Dep. Medical and Health Sciences, Physiotherapy

    Linköping, Östergötland County, 58183

Other trials in Sweden

About this study

Official title: What Does Web-based Neck-specific Exercise Add to a Digital Convergence Dialogue Meeting Promoting the Work Situation for Employees With Neck Pain?

The study will be conducted at workplaces, where the work environment and tasks increase employee risk of developing neck problems. A total of 320 participants will be recruited consecutively and after informed consent randomized to convergenge dialogue meeting with or without neck-specific exercise. The main outcome measure is work ability, measured via the Work Ability Score.

Read the detailed description

Background: Collaboration between employees, manager and occupational health expert is needed to promote work ability. One effective method is a convergence dialogue meeting (CDM). Based on the existing work situation, factors are identified in these meetings that can strengthen the employee's work ability and opportunities for a sustainable working life. A combination of workplace and individual interventions is recommended for best effect. Neck-specific exercise (NSE) is the method with the most evidence for neck problems. NSE in evidence based form has not been investigated for work-related neck pain. More knowledge is needed regarding how CDM can be combined with NSE because clear guidelines are lacking on the best intervention for increased work ability in the case of neck problems. Also lacking are evaluations of digitally distributed CDMs and NSE with support from a web-based program for the current population. The aim of the proposed randomized controlled study is to investigate the contribution of NSE with four visits to a physiotherapist and support from a web-program in addition to three digital CDMs promoting the work situation.

Methods: The study will be conducted at workplaces, where the work environment and tasks increase employee risk of developing neck problems. A total of 320 participants will be recruited consecutively and after informed consent randomized to CDM with or without NSE. The main outcome measure is work ability, measured via the Work Ability Score. Secondary outcome measures are pain, function, health-related quality of life, work absenteeism and presenteeism, work-related factors, and cost-effectiveness. Pathophysiological aspects regarding inflammation and stress markers measured in blood and saliva will be studied, as will muscular changes measured by microdialysis. Interviews are planned with both employees and managers.

Discussion: The goal of the study is to contribute to improved rehabilitation, strengthened work ability, and a sustainable working life for employees with neck problems.

Conditions
Workplace
Being tested
convergence dialogue meeting
Keywords
Neck pain, Workplace, Counceling, Exercise, Internet-based intervention
Medical subject headings
Neck Pain, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • convergence dialogue meetingOther

    Digital counceling with convergence dialogue tripartite meeting. will be conducted in accordance with work dialogue for return to work. Workplace dialogue among employee with neck problems, an expert in the work environment, and the immediate manager. The purpose of the conversations is, in open dialogue, to reach a common understanding of the situation and identify possible interventions to maintain or improve the employee´s work ability.

Study groups in NCT04928989
Study groupRoleWhat they receive
Convergence dialogue meetingActive comparatorDigital counceling with convergence dialogue tripartite meeting. will be conducted in accordance with work dialogue for return to work. Workplace dialogue among employee with neck problems, an expert in the work environment, and the immediate manager. The purpose of the conversations is, in open dialogue, to reach a common understanding of the situation and identify possible interventions to maintain or improve the employee´s work ability.
Receives: Other: convergence dialogue meeting
Neck-specific exercise in addition to convergence dialogue meetingExperimentalNeck-specific exercise with digital web-based support and four visits to a physiotherapist. Neck-specific exercise will be performed based on a well-structured framework of neck-specific exercise for facilitation of deep neck muscles, increased muscle coordination, improved neck posture and increased neck muscle endurance. Plus additional convergence dialogue meeting as treatment arm no 1.
Receives: Other: convergence dialogue meeting

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Work Ability Score

    Current work ability compared to when it was at its best

    Measured: Change in work Ability Score from baseline, to every month until the 15 month follow-up

Secondary outcomes (36)
  1. Intensity of pain and bothersomeness

    neck pain intensity and bothersomeness, headache intensity on a numeric ratin scale.

    Measured: change from baseline to 3 month and 15 month follow-up

  2. Frequency of pain, symtoms and medications

    Frequency of pain, pain medication, neck stiffness, numbness/tingling into the arms, having problems lifting the arms, dizziness, sleep, concentration

    Measured: change from baseline to 3 month and 15 month follow-up

  3. Neck specific function

    Neck Disability Index

    Measured: change from baseline to 3 month and 15 month follow-up

  4. Symptom satisfaction

    Symptom satisfaction according to Cherkin

    Measured: change from baseline to 3 month and 15 month follow-up

  5. Exercise/physical activity level

    Exercise/physical activity level

    Measured: change from baseline to 3 month and 15 month follow-up

  6. Health related quality of life

    EQ-5D-3L

    Measured: change from baseline to 3 month and 15 month follow-up

  7. Fear avoidance

    Fear avoidance beliefs questionnaire

    Measured: change from baseline to 3 month and 15 month follow-up

  8. self rated function

    Patient Specific Functional Scale

    Measured: change from baseline to 3 month follow-up

  9. work situation

    description of work tasks

    Measured: description and change from baseline to 3 month and 15 month follow-up

  10. self-rated work situation regarding working hours

    working hours

    Measured: description and change from baseline to 3 month and 15 month follow-up

  11. perceived exertion at work

    Borg ratings of perceived exertion

    Measured: change from baseline to 3 month and 15 month follow-up

  12. Work ability

    work ability index

    Measured: change from baseline to 3 month and 15 month follow-up

  13. Sick leave,

    sick leave numbers of days/ month

    Measured: change from baseline to 3 month and 15 month follow-up

  14. Presenteeism

    presenteeism number of days/ month and Stanford presenteeism scale

    Measured: change from baseline to 3 month and 15 month follow-up

  15. Effort-Reward Imbalance

    Effort Reward Imbalance questionnaire

    Measured: change from baseline to 3 month and 15 month follow-up

  16. Demand-control, support

    Swedish Demand Control Support Questionnaire which is a short version of the Job centent questionnaire

    Measured: change from baseline to 3 month and 15 month follow-up

  17. Risk identifaction at work

    Structured multidisciplinary work evaluation tool

    Measured: change from baseline to 3 month and 15 month follow-up

  18. work adaptation

    work adaptation such as self strategies to be able to work

    Measured: change from baseline to 3 month and 15 month follow-up

  19. Time sitting

    Time sitting at work and during leisure time

    Measured: change from baseline to 3 month and 15 month

  20. Anxiety and depression

    Hospital Anxiety and Depression scale

    Measured: change from baseline to 3 month and 15 month follow-up

  21. Overall outcome

    Global rating of change scale

    Measured: change from baseline to follw-ups at 3 month and 15 month

  22. Fulfilment of treatment expectation

    Fulfilment of treatment expectation, have your expectations been fulfilled: yes, yes partly, no

    Measured: 3 month and 15 month related to the patient own expectations

  23. Satisfaction with the caregiver visits in the study

    Patient enablement questionnaire

    Measured: 3 month, 15 month

  24. Adverse events/ side-effects

    adverese events/ side effects of treatment in the study

    Measured: 3 month, 15 month

  25. Cost-effectiveness

    Cost effectiveness through calculation of direct costs; quantity and type of care (inside and outside the study also including drugs related to pain) from registers and from questionnaires, indirect costs;mainly production loss from registers and from questionnaire.

    Measured: From the time period between baseline to 15 month follow-up

  26. Saliva samples and blood samples

    Inflammation markers, stress markers. The samples will be taken in the morning on an empty stomach. Saliva will be collected with Salivette. Venous blood samples (10-20 ml) from the elbow fold will be collected in EDTA tubes. identification and quantification of proteins.

    Measured: change from baseline to 3 month in a subgroup of the RCT population, all those who agree and are without contra indication

  27. Microdialysis, tissue changes in the middle Trapezius

    Biomechanical changes interstitialli in M. Trapezius. Through microdialysis technology, it is possible to monitor biochemical changes interstitially in the tissue. The technique involves the exchange of substances via diffusion between the tissue and a diaphragmatic catheter inserted into the tissue and flushed by a fluid (perfusate) that is similar in chemical composition to the fluid in the muscle interstitium.

    Measured: baseline, 3 month, subgroup of the RCT population approximately n=30

  28. Interview study of employers

    employers experience with interventions and their impact on work ability, health and work situation

    Measured: 3 month, subgroup of the RCT population, n=20 approximately

  29. Interview with managers

    Interviews with managers regarding the experience of the convergence dialogue meeting

    Measured: 3 month, approximately n=20

  30. Observation study

    Observation study regarding the interaction between the participants in the converge dialogue meeting. Qualitative data in natural clinical settings of CDMs will be collected through video recordings (≈ 20) to find the meaning of what happen and the interactions during the dialogue. Tripartiate dialogue between patient, manager and care giver regarding the work situation and how to improve it.

    Measured: During the 3 month treatment period at tripartiate convergence dialogue meeting

  31. Health related quality of life on vertical visual analogue scale

    EQ thermometer

    Measured: change from baseline to 3 month and 15 month follow-up

  32. self-rated work situation regarding stress at work

    work stress

    Measured: description and change from baseline to 3 month and 15 month follow-up

  33. self-rated work situation regarding work environment

    work environment

    Measured: description and change from baseline to 3 month and 15 month follow-up

  34. self-rated work situation regarding satisfaction at work

    workplace and work satisfaction

    Measured: description and change from baseline to 3 month and 15 month follow-up

  35. self-rated work situation regarding self-rated work performance

    work performance

    Measured: description and change from baseline to 3 month and 15 month follow-up

  36. self-rated work situation regarding neck position at work

    neck position

    Measured: description and change from baseline to 3 month and 15 month follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jun 2021
  2. Study startMay 2022 (estimated)
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Why it stopped: Lack of funding.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04928989
Sponsor's protocol ID
2021-00373
Acronym
WORKCIT
Status last verified
Apr 2022
First submitted
2 Jun 2021
Last updated
11 Jul 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The data is protected by the Swedish health secrets acts and the European General Data Protection Regulation. Data will be presented on a group level without possibility for individual identification.

Questions about this trial

What is this clinical trial studying?

A study testing convergence dialogue meeting in people with Workplace, run by Linkoeping University at 2 sites in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 11 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Work Ability Score (time frame: Change in work Ability Score from baseline, to every month until the 15 month follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jul 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in